Application Notes
APPLICATION NOTE 2 | Live Cell RNA-Protein interaction Profiling with MTBench®
Drugs targeting RNA-protein interactions are part of the next generation of medicines, but the lack of predictive and cost-effective...
APPLICATION NOTE 1 | When biology drives AI drug design | Optimized iterative cycles for drug discovery
Drug R&D productivity declines The introduction of a new drug to the market is long and costly, taking 10-15 years and requiring $1 to...
News
NOUVELLE SELECTION IA POUR SYNSIGHT AVEC LE “TRUSTED AI START-UP” DECERNé PAR HUB FRANCE IA ET LA EUROPEAN AI STARTUP LANDSCAPE
Le Hub France IA et et la European AI Startup Landscape ont sélectionné SYNSIGHT pour intégrer la nouvelle version de la cartographie...
SYNSIGHT IS selected in France Digitale’s AI Mapping 2021!
France Digitale unveils, on the occasion of France is AI, an exclusive mapping of 502 French startups specialized in artificial...
SYNSIGHT IS SELECTED for the Medicen Paris Region Prize!
Two days ago, Biolabs announced the six selected companies for their Masterclass program. SYNSIGHT founders will be participating in the...
SYNSIGHT IS SELECTED IN SPRING50
SYNSIGHT is selected in 2021 SPRING 50 selection, 50 most innovative and promising start-ups in the Paris-Saclay Innovation Playground...
SYNSIGHT & SERVIER
SYNSIGHT founders talk about the close relationship with the Servier team for the Pharma Day on July 8, 2020. TRANSLATION The robustness...
INVEST4BIOTECH
SYNSIGHT presents its activity to the 1st edition of Invest4biotech at Genopole among 12 start-ups. SYNSIGHT introduces its innovative...
Press Releases
SYNSIGHT SECURES $1.5 MILLION FUNDING ROUND TO ADVANCE ITS DRUG DISCOVERY TECHNOLOGY PLATFORM AND EXPAND ITS PIPELINE
SYNSIGHT, a biotech...
THE IMAGINE INSTITUTE AND SYNSIGHT JOIN FORCES TO GO FURTHER IN DRUG DISCOVERY
Institut Imagine and...
Synsight and MCule combine their AI platform and compound management to boost drug discovery
Online PR News -...
SIGNING OF A MEMORANDUM OF UNDERSTANDING BETWEEN SYNSIGHT AND BIOCUBATE TO DEVELOP AI DRUG DISCOVERY IN ASIAN MARKET
BIOCUBATE, a chinese...
Publications
The FEBS JOURNAL | Identification of a small molecule splicing inhibitor targeting UHM domains
Identification of a small molecule splicing inhibitor targeting UHM domains Abstract Splicing factor mutations are frequent in myeloid...
ELIFE | The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation Abstract TDP-43 is a nuclear RNA-binding protein...
COMMUNICATIONS BIOLOGY | Lin28, a major translayion reprogramming factor, gains acceess to YB-a packaged mRNA through its cold-shock domain
Lin28, a major translation reprogramming factor, gains access to YB-1-packaged mRNA through its cold-shock domain Abstract The RNA-binding...
@SYNSIGHT2021. ALL RIGHTS RESERVED.
Genopole Entreprises
4 rue Pierre Fontaine
91058 EVRY
FRANCE
